Latest Cancer immunotherapy Stories
ImaginAb Expands Portfolio for Immunotherapeutic Drug Development LOS ANGELES, June 3, 2014 /PRNewswire/ -- ImaginAb, Inc.
NEW YORK, June 1, 2014 /PRNewswire/ -- The Cancer Research Institute (CRI) is proud to announce the launch of a first-of-its-kind website devoted to cancer immunotherapy, also called immuno-oncology,
NKTR-214 combined with anti-PD-1 or anti-CTLA-4 provides significant tumor growth inhibition in both EMT6 breast and CT26 colon tumor models SAN FRANCISCO, June 1, 2014 /PRNewswire/
SANTA MONICA, Calif., May 30, 2014 /PRNewswire/ -- Kite Pharma, Inc.
PRINCETON, N.J., May 29, 2014 /PRNewswire/ -- inVentiv Health Clinical, a leading global clinical research organization (CRO), and Advaxis,
Educational and Awareness Raising Events Scheduled throughout the Month of June NEW YORK, May 28, 2014 /PRNewswire/ -- The Cancer Research Institute (CRI) is pleased to host its second annual
-- Ongoing Phase 1 Cancer Immunotherapy Study to be Presented at the Annual Meeting of the American Society of Clinical Oncology -- REDWOOD CITY, Calif., May 28, 2014 /PRNewswire/
SEATTLE, May 27, 2014 /PRNewswire/ -- Adaptive Biotechnologies, the pioneer of Next Generation Sequencing of the adaptive immune system, and its collaborators will present data supporting the
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments.
Created by Society for Immunotherapy of Cancer, this video was created to raise awareness about the excitement and the hope cancer immunotherapy clinical trials can offer patients with NSCLC today.
- A person in a secondary role, specifically the second most important character (after the protagonist).